Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McGill University

$28,000.00

Comprehensive Brachytherapy QA System Based on Radiochromic Film Dosimetry

EF 2023-24

Résumé
Film dosimetry is a powerful tool for radiotherapy treatment verification and quality assurance, as it provides two-dimensional dose distribution captured on a single film sheet. Unlike conventional ones, radiochromic films are special film types that can be handled in daylight and do not need wet processors as they change color after irradiation due to self-inflicted polymerization process within sensitive layer. In the past, we had different models of radiochromic films. The EBT film models have been introduced as a more sensitive alternative to the earlier MD-55 model. During previously NSERC funded grant period we have substantially improved the energy response of the latest EBT3 radiochromic film model. Our group continues with a radiochromic film dosimetry program focused on both fundamental science and clinical implementation of this dosimeter. The absence of a more stringent quality assurance QA process in contact radiotherapy is in sharp contrast with situation for external beam intensity modulated radiation therapies where this is a standard practice. This underscores the need for development of a comprehensive brachytherapy QA system for which we propose advanced film dosimetry to play a central role. Radiochromic Film Dosimetry Based Comprehensive Brachytherapy (RCF-CBT) QA system should consist of the following six components: film protocol, brachytherapy source QA, equipment QA, treatment planning system (TPS) QA, treatment delivery QA, and the appropriate QA software package. The first two components of the proposed RFC-CBT QA system have been already developed over the last 5 years, with the remaining 4 components representing the specific aims for this grant application. First Aim, Equipment QA, will focus on developing phantoms (using 3D printing technology) and procedures for: Auxiliary QA (applicators, catheters, markers), and After-loader QA (delivery of unique radiation patterns). Second Aim, TPS QA, will concentrate on developing end-to-end tests for IGBT, as well as performing retrospective studies on existing IGBT plans to establish acceptance criteria based on dose differences and dose to distance agreements, mimicking IMRT QA procedures. Third Aim, Treatment Delivery QA, will lead to developing methods and procedures for patient dosimetry during treatments. Finally, Fourth Aim in this project is to develop a comprehensive software package that would encompass all five components for the RFC-CBT QA process. Software package will be written in Python, and will be shareware. Software package will incorporate both procedures for dose measurements using radiochromic films and the accompanied analysis modules. It is expected that the shareware software package (developed in this program) would find its use not only for brachytherapy but for other radiotherapy applications and in such a way gain an ultimate credit for Canada as the place where the reference radiochromic film dosimetry was established.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2022-03251
Name nom
DEVIC, SLOBODAN
Department département
Oncology - Oncology
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2022
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Biomedical engineering
Research subject en
Génie biomédical
Research subject fr
Génie biomédical
Application title
Comprehensive Brachytherapy QA System Based on Radiochromic Film Dosimetry
Keyword
Brachytherapy; Dose Escalation; Image Guided Radiotherapy; Quality Assurance; Radiochromic Film
Application summary
Film dosimetry is a powerful tool for radiotherapy treatment verification and quality assurance, as it provides two-dimensional dose distribution captured on a single film sheet. Unlike conventional ones, radiochromic films are special film types that can be handled in daylight and do not need wet processors as they change color after irradiation due to self-inflicted polymerization process within sensitive layer. In the past, we had different models of radiochromic films. The EBT film models have been introduced as a more sensitive alternative to the earlier MD-55 model. During previously NSERC funded grant period we have substantially improved the energy response of the latest EBT3 radiochromic film model. Our group continues with a radiochromic film dosimetry program focused on both fundamental science and clinical implementation of this dosimeter. The absence of a more stringent quality assurance QA process in contact radiotherapy is in sharp contrast with situation for external beam intensity modulated radiation therapies where this is a standard practice. This underscores the need for development of a comprehensive brachytherapy QA system for which we propose advanced film dosimetry to play a central role. Radiochromic Film Dosimetry Based Comprehensive Brachytherapy (RCF-CBT) QA system should consist of the following six components: film protocol, brachytherapy source QA, equipment QA, treatment planning system (TPS) QA, treatment delivery QA, and the appropriate QA software package. The first two components of the proposed RFC-CBT QA system have been already developed over the last 5 years, with the remaining 4 components representing the specific aims for this grant application. First Aim, Equipment QA, will focus on developing phantoms (using 3D printing technology) and procedures for: Auxiliary QA (applicators, catheters, markers), and After-loader QA (delivery of unique radiation patterns). Second Aim, TPS QA, will concentrate on developing end-to-end tests for IGBT, as well as performing retrospective studies on existing IGBT plans to establish acceptance criteria based on dose differences and dose to distance agreements, mimicking IMRT QA procedures. Third Aim, Treatment Delivery QA, will lead to developing methods and procedures for patient dosimetry during treatments. Finally, Fourth Aim in this project is to develop a comprehensive software package that would encompass all five components for the RFC-CBT QA process. Software package will be written in Python, and will be shareware. Software package will incorporate both procedures for dose measurements using radiochromic films and the accompanied analysis modules. It is expected that the shareware software package (developed in this program) would find its use not only for brachytherapy but for other radiotherapy applications and in such a way gain an ultimate credit for Canada as the place where the reference radiochromic film dosimetry was established.